Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number Sort descending | Lead Group | Study Title | CIRB | Study Status | |
|---|---|---|---|---|---|
| 10129 | ETCTN | A Phase 2 Study of the PARP Inhibitor Olaparib (AZD2281) in IDH1 and IDH2 mutant Advanced Solid Tumors | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 10130 | ETCTN | A phase I study of single agent tazemetostat in subjects with advanced solid tumors and B-cell lymphomas with hepatic dysfunction | Adult CIRB - Early Phase Emphasis | Completed | |
| 10131 | ETCTN | A Phase 1 Study of AZD8186 in Combination with Docetaxel in patients with PTEN mutated or PIK3CB mutated advanced solid tumors, potentially amenable to docetaxel | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 10132 | ETCTN | A Phase I Study of the Wee 1 kinase (Wee 1) inhibitor AZD1775 in combination with Radiotherapy and Cisplatin in Cervical, Upper Vaginal and Uterine Cancers (10041848, 10008224, 10008238, 10046888, 10014735) | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 10136 | ETCTN | A Phase 2 Study Of AZD1775, A WEE1 Inhibitor, In Patients With CCNE1 Amplification | Adult CIRB - Early Phase Emphasis | Completed | |
| 10139 | ETCTN | A Randomized Phase 2 Study of Atezolizumab in Combination with Cobimetinib versus Atezolizumab Monotherapy in Participants with Unresectable Cholangiocarcinoma | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 10144 | ETCTN | A Phase II Study of Olaparib (AZD2281) in Patients with Metastatic/Advanced Urothelial Carcinoma with DNA-Repair Defects | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 10145 | ETCTN | Phase 1b Study Of Copanlisib In Combination With Nivolumab Or With Nivolumab And Iplimumab | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 10146 | ETCTN | Randomized phase 2 clinical trial of nab-paclitaxel + MEDI4736 (durvalumab) + tremelimumab + neoantigen vaccine vs. nab-paclitaxel + MEDI4736 (durvalumab) + tremelimumab in patients with metastatic triple negative breast cancer | Adult CIRB - Early Phase Emphasis | Available to Open | |
| 10147 | ETCTN | A Phase II randomized study of topotecan/carboplatin with or without veliparib in advanced myeloproliferative disorders and chronic myelomonocytic leukemia (CMML). | Adult CIRB - Early Phase Emphasis | Available to Open |